| Literature DB >> 35847434 |
Shunsuke Hayakawa1,2, Tetsushi Hayakawa3, Kaori Watanabe1, Kenta Saito2, Hirotaka Miyai1, Ryo Ogawa2, Minoru Yamamoto1, Kenji Kobayashi1, Shuji Takiguchi2, Moritsugu Tanaka1.
Abstract
Aim: This study has two aims: to evaluate long-term chronic pain and complications after circular incision transabdominal preperitoneal inguinal hernia repair (C-TAPP) and compare outcomes of unilateral and bilateral inguinal hernia cases.Entities:
Keywords: chronic pain; inguinal hernia; laparoscopic surgery; propensity repair; recurrence
Year: 2022 PMID: 35847434 PMCID: PMC9271018 DOI: 10.1002/ags3.12556
Source DB: PubMed Journal: Ann Gastroenterol Surg ISSN: 2475-0328
FIGURE 1Peritoneal incision procedure in circular incision transabdominal preperitoneal inguinal hernia repair (C‐TAPP) (right side case). The incision is made by following the blue arrow from the yellow circle on the dorsal side
FIGURE 2Intraoperative photos showing the surgical procedure. (A) The peritoneal incision was made on the dorsal side of the hernia orifice near the outer side the spermatic vessels. (B) The preperitoneal cavity was entered from the medial side of the ductus deferens while preserving the vas deferens and spermatic veins on the abdominal wall. (C) The incision was made at the midline of the inferior epigastric vessels and was intersected with a line from the dorsal side. (D) A space for mesh was created on the myopectineal orifice. (E) Mesh expansion was performed. (F) The peritoneum was closed with continuous sutures
FIGURE 3Schematic diagram showing the appropriate mesh location. Abbreviations: AV, artery and vein
FIGURE 4Questionnaire contents (excerpt from questionnaire sheet)
FIGURE 5Flowchart of TAPP patients who participated in this questionnaire survey. Abbreviations: B, bilateral cases; TAPP, Transabdominal preperitoneal inguinal hernia repair; U, unilateral cases
Patient backgrounds and type of hernia
| Back grounds | All patients | Propensity matching patients | ||||||
|---|---|---|---|---|---|---|---|---|
| U group (1034) | B group (135) |
| U group (135) | B group (135) |
| |||
| Age, years | 63 (55,71) | 69 (62,74) | <.001 | 68 (61,76) | 69 (62,74) | .874 | ||
| Gender (male) | 920 (89.0) | 122 (90.4) | .768 | 117 (86.7) | 122 (90.4) | .446 | ||
| BMI, kg/m2
| 22.8 (21.0, 24.4) |
21.9 (20.4, 23.6 ) | <.001 | 21.4 (20.2, 23.6) | 21.9 (20.4, 23.6) | .367 | ||
| ASA Score (1/2/3/4/5) | 423/605/6/0/0 | 28/105/2/0/0 | <.001 | 31/101/3/0/0 | 28/105/2/0/0 | .786 | ||
| Abdominal surgical history | 343 (33.1) | 52 (38.5) | .246 | 45 (33.3) | 52 (38.5) | .447 | ||
| Antithrombotic therapy | 109 (10.5) | 15 (11.1) | .882 | 14 (10.4) | 15 (11.1) | 1.0 | ||
| Side of hernia defect (Right) | 566 (54.7) | — | — | 86 (63.7) | — | — | ||
|
|
|
|
|
| ||||
| Indirect | 774 (74.9) | 50 (37.0) | 54 (40.0) | — | 91 (67.4) | 50 (37.0) | 54 (40.0) | — |
| Direct | 198 (19.1) | 66 (48.9) | 66 (48.9) | — | 36 (26.7) | 66 (48.9) | 66 (48.9) | — |
| Femoral | 21 (2.0) | 5 (3.7) | 5 (3.9) | — | 5 (3.7) | 5 (3.7) | 5 (3.9) | — |
| Combined | 39 (3.8) | 14 (10.4) | 9 (6.7) | — | 3 (2.2) | 14 (10.4) | 9 (6.7) | — |
| Others | 2 (0.2) | 1 (0.7) | 1 (0.7) | — | 0 | 1 (0.7) | 1 (0.7) | — |
| Size of defect | Right | Left | — | Right | Left | — | ||
| <3.0 | 665 (64.3) | 75 (55.6) | 74 (54.9) | — | 83 (61.5) | 75 (55.6) | 74 (54.9) | — |
|
| 356 (35.7) | 60 (44.4) | 60 (44.4) | — | 52 (38.5) | 60 (44.4) | 60 (44.4) | — |
| Unidentified | 13 (1.3) | 0 | 1 (0.7) | — | 0 | 0 | 1 (0.7) | — |
Data are shown as number of patients (%).
Abbreviations: ASA, American Society of Anesthesiologists; BMI, body mass index.
median, IQR interquartile range (25%, 75%).
Surgical outcome and complications
| Surgical outcome and blood sampling results | All patients | Propensity matching patients | ||||
|---|---|---|---|---|---|---|
| U group (1034) | B group (135) |
| U group (135) | B group (135) |
| |
| Preoperative WBC (/μL) | 5700 (4900‐6800) | 5800 (5100‐6700) | .632 | 5800 (4900‐6950) | 5800 (5100‐6700) | .804 |
| POD1 WBC (/μL) | 7700 (6500‐8850) | 7950 (6650‐9150) | .196 | 7700 (6700‐9150) | 7950 (6650‐9150) | .464 |
| POD1 CRP (mg/dL) | 0.78 (0.47‐1.27) | 1.04 (0.69‐1.95) | <.001 | 0.80 (0.48‐1.42) | 1.04 (0.69‐1.95) | <.001 |
| Operative time (min) | 88 (70‐103) | 132 (104‐158) | <.001 | 82 (69‐82) | 132 (104‐158) | <.001 |
| Amount of bleeding (mL) | 2 (1‐3) | 2 (2‐4) | <.001 | 2 (1‐3) | 2 (2‐4) | <.001 |
| Postoperative hospital stay (days) | 1 (1‐1) | 1 (1‐1) | .119 | 1 (1‐1) | 1 (1‐1) | .739 |
| Proportion able to be discharged on the day after surgery | 1015 (98.2) | 130 (96.3) | .185 | 131 (97.0) | 130 (96.3) | 1.0 |
| Intraoperative complication | 2 (0.2) | 1 (0.7) | .308 | 2 (1.5) | 1 (0.7) | 1.0 |
| Postoperative complications | 21 (2.0) | 4 (3.0) | .520 | 4 (3.0) | 4 (3.0) | 1.0 |
| Clavian‐Dindo classification, | 11 (1.1) | 3 (2.2) | .213 | 1 (0.7) | 3 (2.1) | .622 |
| Clavian‐Dindo classification, (I/II/IIIa/IIIb/IV, V) | 3/7/8/3/0 | 0/1/2/1/0 | .494 | 0/3/0/1/0 | 0/1/2/1/0 | .590 |
| Intraoperative complication | ||||||
| Small bowel injury | 2 (0.2) | 0 | — | 2 (1.5) | 0 | — |
| Remnants of a gauze fragment | 0 | 1 (0.7) | — | 0 | 1 (0.7) | — |
| Postoperative complications | ||||||
| Surgical site infection | 3 (0.3) | 0 | — | 0 | 0 | — |
| Seroma | 7 (0.7) | 2 (1.5) | — | 1 (0.7) | 2 (1.5) | — |
| Additional analgesic medication | 5 (0.5) | 1 (0.7) | — | 0 | 1 (0.7) | — |
| Mesh infection | 0 | 0 | — | 0 | 0 | — |
| Postoperative bleeding | 1 (0.1) | 0 | — | 1 (0.7) | 0 | — |
| Recurrent | 3 (0.3) | 1 (0.7) | — | 0 | 1 (0.7) | — |
| Adhesive intestinal obstruction | 0 | 0 | — | 0 | 0 | — |
| Others | 2 (0.2) | 0 | — | 2 (1.5) | 0 | — |
| Re‐operation | 2 (0.2) | 2 (1.5) | — | 0 | 2 (1.5) | — |
Data are shown as number of patients (%).
Abbreviations: CRP, C‐reactive proteins; POD1, postoperative day 1; WBC, white blood cells.
Needed puncture.
More than Hb2g/dL decrease.
Median, IQR interquartile range (25%, 75%).
Questionnaire results (satisfaction and pain)
| All patients | Propensity matching patients | ||||||
|---|---|---|---|---|---|---|---|
| All cases (1169) | U group (1034) | B group (135) |
| U group (135) | B group (135) |
| |
| Degree of satisfaction (Average) | |||||||
| Very satisfied (9‐10) | 963 (82.4) | 848 (82.0) | 115 (85.2) | .249 | 107 (79.3) | 115 (85.2) | .133 |
| Satisfied (7‐8) | 135 (11.5) | 122 (11.8) | 13 (9.6) | 20 (14.8) | 13 (9.6) | ||
| Normal (5‐6) | 24 (2.1) | 21 (2.0) | 3 (2.2) | 5 (3.7) | 3 (2.2) | ||
| Dissatisfied (3‐4) | 11 (0.9) | 11 (1.1) | 0 | 0 | 0 | ||
| Very dissatisfied (0‐2) | 6 (0.5) | 6 (0.6) | 0 | 0 | 0 | ||
| Blank | 30 (2.6) | 26 (2.5) | 4 (3.0) | 3 (2.2) | 4 (3.0) | ||
| Pain at rest (Average) | |||||||
| No pain (0) | 947 (81.0) | 834 (80.7) | 113 (83.7) | .288 | 113 (83.7) | 113 (83.7) | .726 |
| Mild pain (1‐3) | 163 (13.9) | 146 (14.2) | 17 (12.6) | 16 (11.9) | 17 (12.6) | ||
| Moderate pain (4‐6) | 26 (2.2) | 25 (2.4) | 1 (0.7) | 5 (3.7) | 1 (0.7) | ||
| Severe pain (7‐10) | 12 (1.0) | 11 (1.1) | 1 (0.7) | 0 | 1 (0.7) | ||
| Blank | 21 (1.8) | 18 (1.7) | 3 (2.2) | 1 (0.7) | 3 (2.2) | ||
| Pain at movement (Average) | |||||||
| No pain (0) | 910 (77.8) | 807 (78.0) | 103 (76.2) | .801 | 109 (80.7) | 103 (76.2) | .712 |
| Mild pain (1‐3) | 194 (16.6) | 170 (16.4) | 24 (17.8) | 20 (14.8) | 24 (17.8) | ||
| Moderate pain (4‐6) | 28 (2.4) | 27 (2.6) | 1 (0.7) | 4 (3.0) | 1 (0.7) | ||
| Severe pain (7‐10) | 14 (1.2) | 13 (1.3) | 1 (0.7) | 0 | 1 (0.7) | ||
| Blank | 23 (2.0) | 17 (1.6) | 6 (4.4) | 2 (1.5) | 6 (4.4) | ||
| Mesh discomfort (Average) | |||||||
| No discomfort (0) | 870 (74.4) | 771 (74.6) | 99 (73.3) | .326 | 105 (77.8) | 99 (73.3) | .981 |
| Mild discomfort (1‐3) | 219 (18.7) | 195 (18.9) | 24 (17.8) | 22 (16.3) | 24 (17.8) | ||
| Moderate discomfort (4‐6) | 28 (2.4) | 26 (2.5) | 2 (1.5) | 4 (3.0) | 2 (1.5) | ||
| Severe discomfort (7‐10) | 24 (2.1) | 24 (2.3) | 0 | 1 (0.7) | 0 | ||
| Blank | 28 (2.4) | 18 (1.7) | 10 (7.4) | 2 (1.5) | 10 (7.4) | ||
Data are shown as number of patients (%). The statistical analysis of this table was done in Wilcoxon rank‐sum test.